Viewing StudyNCT01797120



Ignite Creation Date: 2024-05-06 @ 1:22 AM
Last Modification Date: 2024-10-26 @ 11:03 AM
Study NCT ID: NCT01797120
Status: COMPLETED
Last Update Posted: 2018-05-30
First Post: 2013-02-14

Brief Title: Study of Fulvestrant - Everolimus in Post-Menopausal Hormone-Receptor Metastatic Breast Ca Resistant to AI
Sponsor: PrECOG LLC
Organization: PrECOG LLC

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
Keywords:
Name View
Post-Menopausal Patients View
Hormone-Receptor Positive View
Resistant to Aromatase Inhibitor Therapy View
Fulvestrant View
Faslodex View
mTOR Inhibitor View
Everolimus View
RAD001 View
Afinitor View